Success Metrics

Clinical Success Rate
92.3%

Based on 36 completed trials

Completion Rate
92%(36/39)
Active Trials
31(36%)
Results Posted
25%(9 trials)
Terminated
3(3%)

Phase Distribution

Ph not_applicable
26
30%
Ph phase_2
16
18%
Ph phase_1
9
10%
Ph phase_4
4
5%
Ph early_phase_1
1
1%
Ph phase_3
3
3%

Phase Distribution

10

Early Stage

16

Mid Stage

7

Late Stage

Phase Distribution59 total trials
Early Phase 1First-in-human
1(1.7%)
Phase 1Safety & dosage
9(15.3%)
Phase 2Efficacy & side effects
16(27.1%)
Phase 3Large-scale testing
3(5.1%)
Phase 4Post-market surveillance
4(6.8%)
N/ANon-phased studies
26(44.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.7%

36 of 43 finished

Non-Completion Rate

16.3%

7 ended early

Currently Active

31

trials recruiting

Total Trials

87

all time

Status Distribution
Active(33)
Completed(36)
Terminated(7)
Other(11)

Detailed Status

Completed36
Recruiting25
unknown10
Active, not recruiting6
Withdrawn4
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
87
Active
31
Success Rate
92.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.7%)
Phase 19 (15.3%)
Phase 216 (27.1%)
Phase 33 (5.1%)
Phase 44 (6.8%)
N/A26 (44.1%)

Trials by Status

terminated33%
completed3641%
active_not_recruiting67%
suspended11%
unknown1011%
not_yet_recruiting22%
recruiting2529%
withdrawn45%

Recent Activity

Clinical Trials (87)

Showing 20 of 87 trialsScroll for more
NCT06647953Phase 3

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

Recruiting
NCT06809972

Synovial Proliferation on Routine Ultrasound: Active or Inactive?

Recruiting
NCT06952543Not Applicable

Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease

Recruiting
NCT07203911Not Applicable

Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial

Recruiting
NCT00874458Not Applicable

MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ

Completed
NCT06401330Phase 3

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Recruiting
NCT04609046Phase 1

Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma

Recruiting
NCT01696994Not Applicable

Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)

Active Not Recruiting
NCT04384692Phase 2

Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis

Active Not Recruiting
NCT05828082Phase 2

Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer

Active Not Recruiting
NCT01841723Phase 2

Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia

Active Not Recruiting
NCT04251052Not Applicable

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Recruiting
NCT07112053Phase 2

A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

Recruiting
NCT05439850Phase 4

Bioinductive Patch for Full-Thickness Rotator Cuff Tears

Recruiting
NCT05549661Phase 1

Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms

Recruiting
NCT07281547Phase 4

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

Not Yet Recruiting
NCT00352534Phase 3

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor

Active Not Recruiting
NCT06999798Phase 1

An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial

Recruiting
NCT06411795Phase 2

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Recruiting
NCT06060925

Imaging Biomarkers for Myofascial Pain

Completed

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
87